Article ID Journal Published Year Pages File Type
2843954 Physiology & Behavior 2016 8 Pages PDF
Abstract
Atomoxetine boosted NE levels and increased risk taking. This was because atomoxetine decreased rats' sensitivity to losses. These effects were likely mediated by beta-adrenoreceptor.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Physiology
Preview
Beta-adrenoreceptor blockade abolishes atomoxetine-induced risk taking
Authors
, , ,